These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22622033)

  • 1. Getting to the finish line with mTORC1-targeted therapy.
    Henske E
    J Clin Invest; 2012 Jun; 122(6):1970-2. PubMed ID: 22622033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 is essential for leukemia propagation but not stem cell self-renewal.
    Hoshii T; Tadokoro Y; Naka K; Ooshio T; Muraguchi T; Sugiyama N; Soga T; Araki K; Yamamura K; Hirao A
    J Clin Invest; 2012 Jun; 122(6):2114-29. PubMed ID: 22622041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.
    Altman JK; Sassano A; Kaur S; Glaser H; Kroczynska B; Redig AJ; Russo S; Barr S; Platanias LC
    Clin Cancer Res; 2011 Jul; 17(13):4378-88. PubMed ID: 21415215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Ghosh J; Kapur R
    Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
    Tamburini J; Green AS; Bardet V; Chapuis N; Park S; Willems L; Uzunov M; Ifrah N; Dreyfus F; Lacombe C; Mayeux P; Bouscary D
    Blood; 2009 Aug; 114(8):1618-27. PubMed ID: 19458359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells.
    Marzec M; Liu X; Wysocka M; Rook AH; Odum N; Wasik MA
    PLoS One; 2011; 6(9):e24849. PubMed ID: 21949767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targeting.
    Altman JK; Szilard A; Goussetis DJ; Sassano A; Colamonici M; Gounaris E; Frankfurt O; Giles FJ; Eklund EA; Beauchamp EM; Platanias LC
    Clin Cancer Res; 2014 May; 20(9):2400-9. PubMed ID: 24610825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival.
    Feng Y; Wu L
    Biochem Biophys Res Commun; 2017 Feb; 483(2):897-903. PubMed ID: 28082200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia.
    Fang Y; Yang Y; Hua C; Xu S; Zhou M; Guo H; Wang N; Zhao X; Huang L; Yu F; Cheng H; Wang ML; Meng L; Cheng T; Yuan W; Ma D; Zhou J
    Leukemia; 2017 Feb; 31(2):414-422. PubMed ID: 27499138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.
    Dai Q; Xie F; Han Y; Ma X; Zhou S; Jiang L; Zou W; Wang J
    J Biol Chem; 2017 Jan; 292(1):196-204. PubMed ID: 27879318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation.
    Foster KG; Acosta-Jaquez HA; Romeo Y; Ekim B; Soliman GA; Carriere A; Roux PP; Ballif BA; Fingar DC
    J Biol Chem; 2010 Jan; 285(1):80-94. PubMed ID: 19864431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting translation in acute myeloid leukemia: a new paradigm for therapy?
    Tamburini J; Green AS; Chapuis N; Bardet V; Lacombe C; Mayeux P; Bouscary D
    Cell Cycle; 2009 Dec; 8(23):3893-9. PubMed ID: 19934662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of mTORC1 in acute myeloid leukemia].
    Hoshii T; Hirao A
    Rinsho Ketsueki; 2015 Apr; 56(4):359-65. PubMed ID: 25971265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Raptor by p38beta participates in arsenite-induced mammalian target of rapamycin complex 1 (mTORC1) activation.
    Wu XN; Wang XK; Wu SQ; Lu J; Zheng M; Wang YH; Zhou H; Zhang H; Han J
    J Biol Chem; 2011 Sep; 286(36):31501-11. PubMed ID: 21757713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
    Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
    Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.
    Kalaitzidis D; Sykes SM; Wang Z; Punt N; Tang Y; Ragu C; Sinha AU; Lane SW; Souza AL; Clish CB; Anastasiou D; Gilliland DG; Scadden DT; Guertin DA; Armstrong SA
    Cell Stem Cell; 2012 Sep; 11(3):429-39. PubMed ID: 22958934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor.
    Hussain S; Feldman AL; Das C; Ziesmer SC; Ansell SM; Galardy PJ
    Mol Cell Biol; 2013 Mar; 33(6):1188-97. PubMed ID: 23297343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia.
    Willems L; Chapuis N; Puissant A; Maciel TT; Green AS; Jacque N; Vignon C; Park S; Guichard S; Herault O; Fricot A; Hermine O; Moura IC; Auberger P; Ifrah N; Dreyfus F; Bonnet D; Lacombe C; Mayeux P; Bouscary D; Tamburini J
    Leukemia; 2012 Jun; 26(6):1195-202. PubMed ID: 22143671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.